DYAI.US Dyadic International Inc

Healthcare Biotechnology USA Stocks
0.3270 USD
Close of Nov 14, 2026
0.3200 1.60
Market cap
USD 13.1M
P/E
-
P/B
11.03x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DYAI.US undervalued?

Graham number

The Graham number of Dyadic International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dyadic International Inc fundamental analysis

No fundamental analysis for Dyadic International Inc yet.

Dyadic International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dyadic International Inc

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fung…

Full company profile